Long Wang, MD, PhD, is a seasoned pharmaceutical development executive with over 20 years leadership spanning clinical development, regulatory strategy, global submissions and health authority interactions. As SVP, Head of Regulatory Affairs at Mineralys Therapeutics, he owns the enterprise regulatory strategy for a cardiovascular portfolio. Prior to that, he led the development, approval and launch of over 10 innovative products at GSK, Merck and Takeda.
